Skip to main content
Explore URMC

menu

Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER

Research Question:
Is the drug bardoxolone safe and tolerable in patients who have participated in a bardoxolone in the past?

Basic Study Information

Purpose:
This extended access study will assess the long-term safety and tolerability of bardoxolone methyl in qualified patients with pulmonary hypertension (PH) who previously participated in controlled clinical studies with bardoxolone methyl.

Location: University of Rochester - University of Rochester Medical Center

Study Contact Information

Study Coordinator: Lacey Powers
Phone: (972) 865-2219
Email: ranger@reatapharma.com

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search